Effect of Long-Term Administration of a Prolonged Release Formulation of Bovine Somatotropin (Sometribove) On Clinical Lameness in Dairy- Cows

By Cole, W. J. and Collier, R. J. and Trent, A. M. and Wells, S. J., American Journal of Veterinary Research, 1995
Research Paper Web Link / URL:
A matched case-control study design was used to assess the effects of long-term administration of a prolonged release formulation of bovine somatotropin (sometribove) on clinical lameness and limb lesions in dairy cows. Cows treated with sometribove for at least 2 lactations (cases) and nontreated dairy cows matched by herd, parity, age, and stage of lactation (controls) in 8 herds were evaluated for clinical lameness (as assessed by gait abnormality) and limb lesions by 2 observers, using a standardized scoring procedure at a single herd visit. Although a high proportion of the study cows were clinically lame (43%), an association was not detected between chronic administration of sometribove and prevalent lameness. Of 21 types of limb lesions identified, 2 were positively associated and 2 were negatively associated with long-term sometribove use. Superficial laceration of the tarsus (odds ratio [OR] = 2.1) and superficial swelling of the metatarsophalangeal joint (OR = 4.5) were positively associated with sometribove treatment, whereas femoral lesions (on = 0.2) and superficial lacerations of the femur (OR = 0.14) were negatively associated with sometribove treatment
We welcome and encourage discussion of our linked research papers. Registered users can post their comments here. New users' comments are moderated, so please allow a while for them to be published.

Leave a Reply